Source: DGNews  |  Posted 8 years ago

MADISON, NJ -- March 13, 2002 -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the U.S. Food and Drug Administration (FDA) has approved a new lower dose of Prempro